Understanding how to improve immunotherapy for aggressive brain tumors in children
Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology
This study is looking at a tough type of brain tumor in kids called high-risk Group 3 medulloblastoma, and it's trying to find out how these tumors hide from the immune system so that new treatments can be created to help the immune system fight them better.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | St. Jude Children's Research Hospital NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-10924068 on NIH RePORTER |
What this research studies
This research focuses on high-risk Group 3 medulloblastoma, a severe type of brain tumor in children. The team aims to uncover how these tumors evade the immune system and to develop effective immunotherapy treatments. Using advanced techniques like single-cell profiling and CRISPR-based screening, they will analyze the tumor environment and identify new targets for therapy. This approach is designed to enhance the immune response against these tumors, potentially leading to better treatment options for affected children.
Who could benefit from this research
Good fit: Ideal candidates for this research are children under 11 years old diagnosed with high-risk Group 3 medulloblastoma.
Not a fit: Patients with other types of brain tumors or those over the age of 11 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new immunotherapy treatments that significantly improve survival rates for children with high-risk Group 3 medulloblastoma.
How similar studies have performed: Previous studies using systems immunology approaches have shown promise in other cancer types, suggesting potential for success in this novel application.
Where this research is happening
Memphis, United States
- St. Jude Children's Research Hospital — Memphis, United States (Active)
Researchers
- Principal investigator: Chi, Hongbo — St. Jude Children's Research Hospital
- Study coordinator: Chi, Hongbo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.